Send the following on WhatsApp
Continue to ChatSirnaomics核酸干擾候選藥物STP707通過靜脈給藥用於原發硬化性膽管炎治療的IND已獲FDA安全放行 https://geneonline.news/fda-sirnaomics-stp707/
Sirnaomics核酸干擾候選藥物STP707通過靜脈給藥用於原發硬化性膽管炎治療的IND已獲FDA安全放行 https://geneonline.news/fda-sirnaomics-stp707/